Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Viewray, Inc. (VRAY)  
$0.00 0.00 (0.00%) as of 4:30 Tue 4/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 164,320,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.000001 - $0.8281
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   ViewRay designs, manufactures and markets the ViewRay MRIdian® MRI-Guided Radiation Therapy System. MRIdian is built upon a proprietary magnetic resonance imaging (MRI) system to address the challenges and clinical workflow for radiation oncology. The MRIdian MR-Guided Radiation Therapy System integrates diagnostic-quality MRI with radiation therapy delivery to enable on-table adaptive treatments with real-time tissue tracking and automatic beam gating. Co.'s generations of the MRIdian are: the MRIdian with Cobalt-60 based radiation beams and MRIdian Linac, with linear accelerator or linac based radiation beams.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 71,000
Total Buy Value $0 $0 $0 $252,506
Total People Bought 0 0 0 2
Total Buy Transactions 0 0 0 4
Total Shares Sold 0 0 13,487,227 13,529,227
Total Sell Value $0 $0 $844,275 $1,017,735
Total People Sold 0 0 8 9
Total Sell Transactions 0 0 11 12
End Date 2024-02-15 2023-11-14 2023-05-16 2022-05-16

   
Records found: 318
  Page 8 of 13  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Drake Scott William President & CEO   •       •      –    2019-10-24 4/A D $0.00 $0 D/D (744,091) 1,862,892     -
   Knaley Brian Sr VP and Interim CFO   •       –      –    2019-10-24 4 A $0.00 $0 D/D 100,000 101,075     -
   Alecxih James Chief Commercial Officer   •       –      –    2019-10-24 4 A $0.00 $0 D/D 240,000 278,371     -
   Drake Scott William President & CEO   •       •      –    2019-10-24 4 A $0.00 $0 D/D 1,250,000 2,606,983     -
   Matin Shahriar Chief Operating Officer   •       –      –    2019-10-24 4 A $0.00 $0 D/D 625,000 1,292,862     -
   Dempsey James F. Chief Scientific Officer   •       •      –    2019-10-24 4 A $0.00 $0 D/D 230,000 450,973     -
   Knaley Brian Sr VP and Interim CFOOfficer   •       –      –    2019-10-01 3 IO $0.00 $0 D/D 0 1,075     -
   Dempsey James F. Chief Scientific Officer   •       •      –    2019-09-03 4 AS $3.57 $996,390 D/D (279,414) 220,973     -
   Dempsey James F. Chief Scientific Officer   •       •      –    2019-09-03 4 OE $0.68 $191,267 D/D 279,414 284,230     -
   Matin Shahriar Chief Operating Officer   •       –      –    2019-08-14 4 B $4.02 $241,200 D/D 60,000 667,862 2.74     -
   Drake Scott William President & CEO   •       •      –    2019-08-13 4 B $3.81 $500,048 D/D 131,260 1,356,983 2.81     -
   Wilensky Gail R Director   –       •      –    2019-08-01 4/A A $0.00 $0 D/D 26,360 28,819     -
   Wilensky Gail R Director   –       •      –    2019-08-01 4 A $8.82 $57,498 D/D 6,519 8,978     -
   Dempsey James F. Chief Scientific Officer   •       •      –    2019-08-01 4 AS $8.97 $193,980 D/D (21,615) 220,973     -
   Dempsey James F. Chief Scientific Officer   •       •      –    2019-08-01 4 OE $0.68 $14,698 D/D 21,615 237,442     -
   Bansal Ajay Chief Financial Officer   •       –      –    2019-07-25 4 D $9.00 $39,672 D/D (4,408) 98,876     -
   Bansal Ajay Chief Financial Officer   •       –      –    2019-07-25 4 OE $3.17 $39,685 D/D 12,519 103,284     -
   Matin Shahriar Chief Operating Officer   •       –      –    2019-07-22 4 D $9.49 $803,442 D/D (84,662) 607,862     -
   Drake Scott William President & CEO   •       •      –    2019-07-22 4 D $9.49 $1,606,885 D/D (169,324) 1,225,723     -
   Wilensky Gail R Director   –       •      –    2019-07-16 4 A $9.19 $22,598 D/D 2,459 2,459     -
   Dempsey James F. Chief Scientific Officer   •       •      –    2019-07-01 4/A AS $8.63 $186,668 D/D (21,615) 220,973     -
   Dempsey James F. Chief Scientific Officer   •       •      –    2019-07-01 4/A OE $0.68 $14,698 D/D 21,615 237,442     -
   Dempsey James F. Chief Scientific Officer   •       •      –    2019-07-01 4 AS $8.63 $44,431 D/D (5,146) 317,498     -
   Matin Shahriar Chief Operating Officer   •       –      –    2019-03-01 4 A $0.00 $0 D/D 90,024 692,524     -
   Drake Scott William President & CEO   •       •      –    2019-03-01 4 A $0.00 $0 D/D 180,047 1,395,047     -

  318 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 8 of 13
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed